Multisystem involvement in neuromyelitis optica

Annals of Indian Academy of Neurology

Volumn 18, Issue , 2015, Pages S56-S58

  Langille, Megan ^a   Desai, Jay ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Adenopathy; hyperCKemia; lung consolidation; neuromyelitis optica; NMO

Indexed keywords

AQUAPORIN 4; CREATINE KINASE; FRUCTOSE BISPHOSPHATE ALDOLASE; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; RITUXIMAB;

ADOLESCENT; AREA POSTREMA; AREA POSTREMA SYNDROME; ARTICLE; AXILLARY ADENOPATHY; BLINDNESS; BRAIN DISEASE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CRANIAL NERVE PARALYSIS; DRUG PULSE THERAPY; FEMALE; HILAR ADENOPATHY; HUMAN; IMMUNOMODULATION; LUNG DISEASE; LYMPHADENOPATHY; MULTIPLE CYCLE TREATMENT; MYELOOPTIC NEUROPATHY; MYOSITIS; NAUSEA AND VOMITING; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PROTEIN BLOOD LEVEL; THORAX RADIOGRAPHY; WEIGHT REDUCTION;

EID: 84942121259     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: 10.4103/0972-2327.164830     Document Type: Article

References (18)

1. Jarius S, Wildemann B. On the contribution of Thomas Clifford Allbutt, F.R.S., to the early history of neuromyelitis optica. J Neurol 2013;260:100-4.
2. Gault F. The neuromyelitis optica. Thesis presented to Faculty of Medicine and Pharmacy in Lyon. 1894.
3. Devic E. Myelitesubaiguecompliquee de neuriteoptique. Bull Med 1894;8:1033-4.
4. Lennon VA, Wingerchuk DM, Kryzer TJ. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 2004;364:2106-12.
5. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-9.
6. Wingerchuk D, Banwell B, Bennett J, Cabre P, Carroll W, Chitnis T, et al. Revised Diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2014;82:10.
7. Verkman AS. Aquaporins in clinical medicine. Annu Rev Med 2012;63:303-16.
8. Verkman AS. Role of aquaporins in lung liquid physiology. Respir Physiol Neurobiol 2007;159:324-30.
9. Suzuki N, Takahashi T, Aoki M, Misu T, Konohana S, Okumura T, et al. Neuromyelitis optica preceded by hyperCKemia episode. Neurology 2010;74:1543-5.
10. Deguchi S, Deguchi K, Sato K, Yunoki T, Omote Y, Morimoto N, et al. HyperCKemia related to the initial and recurrent attacks of neuromyelitis optica. Intern Med 2012;51:2617-20.
11. Okada H, Wada M, Sato H, Yamaguchi Y, Tanji H, Kurokawa K, et al. Neuromyelitisoptica preceded by hyperCKemia and a possible association with coxsackie virus group A10 infection. Intern Med 2013;52:2665-8.
12. Malik R, Lewis A, Cree BA, Ratelade J, Rossi A, Verkman AS, et al. Transient hyperCKemia in the setting of neuromyelitisoptica (NMO). Muscle Nerve 2014;50:859-62.
13. Di Filippo M, Franciotta D, Massa R, Di Gregorio M, Zardini E, Gastaldi M, et al. Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitisoptica. Neurology 2012;79:1182-4.
14. Yokoyama N, Niino M, Takahashi T, Matsushima M, Maruo Y. Seroconversion of neuromyelitisoptica spectrum disorder with hyperCKemia: A case report. Eur J Neurol 2012;19:e143.
15. Guo Y, Lennon VA, Popescu BF, Grouse CK, Topel J, Milone M, et al. Autoimmune Aquaporin-4 Myopathy in Neuromyelitis optica spectrum. JAMA Neurol 2014;71:1025-9.
16. Sawaya R, Radwan W. Sarcoidosis associated with neuromyelitis optica. J Clin Neurosci 2013;20:1156-8.
17. Wingerchuk DM, Weinshenker BG. The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult Scler 2012;18:5-10.
18. Enzenauer RJ, West SG. Sarcoidosis in autoimmune disease. Semin Arthritis Rheum 1992;22:1-17.